Olympus Corporation (OCPNF)
OTCMKTS · Delayed Price · Currency is USD
12.42
0.00 (0.00%)
At close: Sep 9, 2025
Olympus Market Cap
Olympus has a market cap or net worth of $14.07 billion as of September 18, 2025. Its market cap has decreased by -33.87% in one year.
Market Cap
14.07B
Enterprise Value
14.31B
Revenue
6.72B
Ranking
n/a
PE Ratio
18.08
Stock Price
$12.42
Market Cap Chart
Since January 16, 1992, Olympus's market cap has increased from 2.39B to 14.07B, an increase of 487.93%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 14.20B | -16.50% |
| Dec 30, 2024 | 17.01B | -1.61% |
| Dec 29, 2023 | 17.29B | -23.63% |
| Dec 30, 2022 | 22.64B | -23.48% |
| Dec 30, 2021 | 29.58B | 5.35% |
| Dec 30, 2020 | 28.08B | 40.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 359.27M |
| American Oncology Network | 353.52M |